![Fergus Fleming](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermogen: 14 422 $ op 31-05-2026
Fergus Fleming is currently the Director & Chief Technology Officer at Renalytix Plc.
Previously, he worked as the Managing Director at Ff Consulting Ltd. from 2014 to 2018.
He also served as the Head-Business Development at Oncomark Ltd. from 2016 to 2018.
Mr. Fleming completed his undergraduate degree at the National University of Ireland Galway.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
RENALYTIX PLC 0,14% | 20-12-2024 | 594.481 ( 0,14% ) | 14 422 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| RENALYTIX PLC | Hoofd Techniek/Wetenschap/O&O | 15-03-2018 |
| Bedrijven | Functie | Einde |
|---|---|---|
Ff Consulting Ltd. | Algemeen Directeur | 01-11-2018 |
Oncomark Ltd.
 Oncomark Ltd. Medical SpecialtiesHealth Technology Operates as a diagnostics company that develops novel cancer biomarkers | Corporate Officer/Principal | 01-10-2018 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 4 |
|---|---|
Oncomark Ltd.
Oncomark Ltd. Medical SpecialtiesHealth Technology Operates as a diagnostics company that develops novel cancer biomarkers | Health Technology |
National University of Ireland Galway
 National University of Ireland Galway Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Renalytix Plc
 Renalytix Plc Packaged SoftwareTechnology Services Provides artificial intelligence for kidney disease | Technology Services |
Ff Consulting Ltd. |
Kies jouw editie
Alle financiële informatie op nationaal niveau
